In older adults with type 2 diabetes, GLP-1 agonists decrease major adverse cardiovascular events; SGLT2 inhibitors prevent heart failure hospitalizations
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "In Older Adults With Type 2 Diabetes, GLP-1 Agonists Decrease Major Adverse Cardiovascular Events; SGLT2 Inhibitors Prevent Heart Failure Hospitalizations." EE+ POEM Archive, John Wiley & Sons, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377245/all/In_older_adults_with_type_2_diabetes__GLP_1_agonists_decrease_major_adverse_cardiovascular_events.
In older adults with type 2 diabetes, GLP-1 agonists decrease major adverse cardiovascular events; SGLT2 inhibitors prevent heart failure hospitalizations. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2024. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377245/all/In_older_adults_with_type_2_diabetes__GLP_1_agonists_decrease_major_adverse_cardiovascular_events. Accessed November 8, 2024.
In older adults with type 2 diabetes, GLP-1 agonists decrease major adverse cardiovascular events; SGLT2 inhibitors prevent heart failure hospitalizations. (2024). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377245/all/In_older_adults_with_type_2_diabetes__GLP_1_agonists_decrease_major_adverse_cardiovascular_events
In Older Adults With Type 2 Diabetes, GLP-1 Agonists Decrease Major Adverse Cardiovascular Events; SGLT2 Inhibitors Prevent Heart Failure Hospitalizations [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2024. [cited 2024 November 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377245/all/In_older_adults_with_type_2_diabetes__GLP_1_agonists_decrease_major_adverse_cardiovascular_events.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - In older adults with type 2 diabetes, GLP-1 agonists decrease major adverse cardiovascular events; SGLT2 inhibitors prevent heart failure hospitalizations
ID - 3377245
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377245/all/In_older_adults_with_type_2_diabetes__GLP_1_agonists_decrease_major_adverse_cardiovascular_events
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -